Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Community helpers may boost kidney transplant access

NCT ID NCT06655857

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether community health workers and special training for doctors can help more kidney patients get on the transplant waitlist. Five patients will be assigned to either usual care or extra support from a community health worker who addresses social needs like housing or food. The goal is to see if this approach speeds up the waitlisting process.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Community health worker assistance and provider education
What this could lead to
If successful, this could show a way to help more kidney patients get on the transplant waitlist by addressing social needs and reducing bias.
What could go wrong
This is a very small pilot study with only 5 participants, so results may not apply to larger groups. It tests a process, not a treatment, so impact is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient inclusion: * Provision of signed and dated informed consent from the patient. * Stated willingness to comply with all study procedures and availability for the duration of the study. * Age 18 - 75 years * eGFR≤20 mL/min/1.73m2 or on maintenance in-center HD. * Receive kidney care at Mount Sinai, Einstein, Bellevue Hospital, NYU, or hemodialysis at a participating HD Center. * Community dwelling (i.e., not in a nursing home, currently incarcerated). * Speak English and/or Spanish. * Provider Inclusion: * Provision of signed and dated informed consent from the nephrologist. * Stated willingness to comply with all study procedures and availability for the duration of the study. Exclusion Criteria: * Patient Exclusion: * Absolute contraindications to KTx: * Self-reported or documented diagnosis of dementia, or inability to understand the study and complete informed consent. When the participant's understanding is unclear, the CRC will use a modified MOCA screener to determine eligibility. * Active malignancy (excluding local non-melanoma skin cancer, renal cell carcinoma \<5 cm, early thyroid cancer, and prostate cancer GS≤6). * Pregnancy (can be re-evaluated post-delivery). * Active infection. Patients excluded due to active infection will be evaluated at 30 days or after completing full treatment (whichever is later) to determine eligibility. Examples of active infection include: * Positive cultures or radiographic evidence of infection * Infected intravascular devices, such as tunneled catheters and pacemakers * Active histoplasmosis, cryptococcosis, tuberculosis (TB), and nontuberculous mycobacteria * Previously evaluated by KTx and not listed for specific medical reasons. * Patients previously evaluated and not listed will be carefully reviewed by site PI for eligibility * Already listed for KTx. * Patients on other types of dialysis other than in-center hemodialysis. * Self-identify as already engaged with a CHW at participating sites to address unmet social needs. * Planning to move out of the greater NY area in the next 1 year. * Provider Exclusion: * Planning to leave their respective institutions in the next 1 year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Montefiore Einstein

    NOT_YET_RECRUITING

    The Bronx, New York, 10467, United States

  • Mount Sinai Hospital

    RECRUITING

    New York, New York, 10029, United States

  • NYU Langone Health

    NOT_YET_RECRUITING

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.